FOXO3 and benign prostatic hyperplasia: Based on these findings, the authors suggested that resveratrol activated p38 MAPK and suppressed FOXO3a, thereby suppressing antioxidative activity and increasing ROS accumulation, leading to the apoptosis of BPH-1 cells [121].